6981 Murata Manufacturing Co. Ltd.

Murata’s Revolutionary Stretchable Printed Circuit Elevates Wearable Medical Devices

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) reveals an innovative new Stretchable Printed Circuit (SPC) technology marking a significant development in printed circuit technology. Murata's SPC represents the next advancement in substrate development, providing both flexibility and the capability to stretch and deform while maintaining full functionality. It is perfect for creating advanced medical products, like wearable therapeutic devices and vital monitoring tools, that can provide better accuracy, durability, and patient comfort than today’s equivalent devices.

This press release features multimedia. View the full release here:

[Murata Manufacturing Co., Ltd.] Murata’s Stretchable Printed Circuit (SPC) (Photo: Business Wire)

[Murata Manufacturing Co., Ltd.] Murata’s Stretchable Printed Circuit (SPC) (Photo: Business Wire)

In recent years, in the medical field, to make more accurate diagnoses, the importance of sophisticated tests performed in hospitals and biometric information collected continuously in daily life has increased. Daily vital sign monitoring is important to prevent lifestyle-related diseases, therefore wearable medical devices are now ubiquitous. However, existing devices are often too stiff for many applications, creating issues like patient discomfort, poor surface contact, or unstable data acquisition. Murata's SPC excels in its inherent flexibility, stretchability, and ability to adapt, supporting multi-sensing functionalities to address diverse user requirements. The material is incredibly soft and gentle on the skin, making it ideal for medical and wellness devices like EEG (Electroencephalogram), EMG (Electromyogram), and ECG (Electrocardiogram). Its stretchable nature can enable a single device to accommodate various body areas and patients of different sizes, as well as allowing more easily for continuous monitoring applications or monitoring in previously challenging areas such as elbows or knee joints.

Engineered with cutting-edge capabilities, including printing stretchable electrodes compliant with ANSI/AAMI EC12 standards, SPC paves the way for next-generation medical devices. It achieves seamless integration and optimal performance through innovative telescopic component mounting and hybrid bonding technology between substrates. By effectively blocking electromagnetic noise, the unique shield layer offers reliable protection for the signal path. Additionally, the substrate construction demonstrates excellent reliability, with high resistance to moisture and the ability to withstand high voltages for long durations, while allowing for more flexibility in component mounting, giving designers more freedom to innovate.

Murata's SPC can be tailored to meet individual customer specifications with the help of Murata’s extensive range of resources to facilitate collaborative product development. This can be harnessed by product designers, enabling them to optimize their designs. Murata can further support development by conducting tests in various conditions and resolving failure modes by identifying their root causes. Depending on the required specifications, filters, amplifiers, and multiple sensors can be mounted on a single sheet, enabling accurate data acquisition and sensing of several items. With this solution, Murata performs custom design, prototyping and verification, and mass production based on the required specifications.

For further details or to request samples of Murata’s SPC solutions, you can contact your local Murata representation, or reach out via the . You can find the product webpage .

EN
07/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Murata Manufacturing Co. Ltd.

Pelham Smithers
  • Pelham Smithers

PSA Technology: Why AI is More of a “Win” than a “Loss” for Japanese M...

Analyst Pelham Smithers discusses why Japan’s MLCC makers are in the sweet spot to benefit from the AI boom. Consequently, Murata’s earnings should expand at +19% CAGR over FY25~FY27, with OPMs rising from 15% to 21%.

Pelham Smithers
  • Pelham Smithers

PSA Electronic Components: Review of Murata's (6981 JT) FY25 Q3

Pelham Smithers reviews the FY25 Q3 performance of Murata and highlights what is going right and what isn’t.

Pelham Smithers
  • Pelham Smithers

PSA Strategy: Japan Stock Market Quarterly for 2025 Q4

For almost three years the Nikkei 225 has been tracking its performance from the 2003~5 bull market, albeit at levels some 3.3x higher In this report, Pelham Smithers discusses the similarities and asks three key questions: (1) Can we continue to track 2005 through the rest of the year; (2) Whatever happens in Q4, should we fear or be hopeful for 2026? And (3) Who are the upcoming winners and losers.

Pelham Smithers
  • Pelham Smithers

PSA Technology: Japanese AI Stocks Revisited

At first glance, it feels like the Japanese stock market has reacted unusually slowly to the surge in AI infrastructure stocks in the US. Pelham Smithers flags winners on this theme.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch